MONTREAL–( COMPANY CORD)– Path today introduced that its exclusive large-language design (LLM) racked up 96% on a validated collection of USA Medical Licensing Evaluation (USMLE) inquiries, the greatest precision yet reported for a specific clinical AI. The outcome enhances Path’s setting as a leading evidence-based decision-support device for frontline medical professionals. In neck and neck screening, Path’s “Deep” AI design went beyond domain-specific peers MediSearch Pro, OpenEvidence and Hippoc
发布者：Dr.Durant，转转请注明出处：https://robotalks.cn/pathway-sets-a-new-benchmark-for-specialty-medical-ai-with-transparent-just-in-time-reasoning/
